口腔临床营养市场－全球产业规模、份额、趋势、机会和预测（按适应症、配销通路、地区和竞争细分，2020-2030 年）

2024 年全球口腔临床营养市场价值为 158.9 亿美元，预计到 2030 年将达到 221.4 亿美元，预测期内的复合年增长率为 5.68%。由于慢性病发病率不断上升、对以患者为中心的护理的更加重视以及营养不良、肌少症和恶病质等疾病的盛行率不断上升，市场正在经历强劲增长。这些因素推动了对口腔临床营养产品的需求，这些产品为无法透过常规食物摄取满足饮食需求的患者提供必需的营养素。市场涵盖广泛的产品，例如营养补充剂、肠内配方和医疗食品，所有这些产品均旨在支持患者康復并在临床环境中保持健康。

关键市场驱动因素

老年人口增加及相关营养不良风险

主要市场挑战

发展中地区的高成本和有限的报销

主要市场趋势

临床营养配方的个人化

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球口腔临床营养市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依适应症（阿兹海默症、营养不良、癌症照护、慢性肾臟病、吞嚥困难等）
  • 按配销通路（直接销售与间接销售）
  • 按地区
  • 按公司分类（2024）
• 产品图
  • 按适应症
  • 按配销通路
  • 按地区

第六章：北美口腔临床营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲口腔临床营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太口腔临床营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲口腔临床营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲口腔临床营养市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球口腔临床营养市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Bayer AG
• Nestle SA
• GlaxoSmithKline plc.
• Baxter International Inc.
• Otsuka Holdings, Co. Ltd.
• Baxter International Inc.
• Victus, Inc.
• Danone SA(Nutricia)

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Oral Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is projected to reach USD 22.14 billion by 2030, growing at a CAGR of 5.68% during the forecast period. The market is witnessing strong growth due to increasing incidences of chronic diseases, greater emphasis on patient-focused care, and the rising prevalence of conditions like malnutrition, sarcopenia, and cachexia. These factors are driving demand for oral clinical nutrition products, which provide essential nutrients to patients who are unable to meet their dietary needs through regular food intake. The market comprises a broad range of products, such as nutritional supplements, enteral formulas, and medical foods, all formulated to support patient recovery and maintain health in clinical settings.

Key Market Drivers

Increasing Geriatric Population and Associated Malnutrition Risks

The global rise in the aging population is a key driver fueling demand for oral clinical nutrition products. As individuals age, they commonly experience reduced appetite, decreased digestive efficiency, and lower nutrient intake-factors that contribute to malnutrition, muscle loss, and weakened immunity. Oral clinical nutrition provides a solution by offering nutrient-dense formulations that are easy to consume and digest. According to the World Health Organization, by 2030, one in six people worldwide will be aged 60 years or older, and this number is expected to double by 2050. With aging comes a higher incidence of chronic diseases and nutritional deficiencies, positioning oral clinical nutrition as an essential component of elderly healthcare.

Key Market Challenges

High Cost and Limited Reimbursement in Developing Regions

The high cost of specialized oral clinical nutrition products remains a significant barrier, particularly in low- and middle-income countries. These products are often not included in government-funded health insurance schemes or essential medicine lists, placing the financial burden on patients and caregivers. Limited reimbursement policies restrict widespread adoption, particularly in underserved areas where healthcare access is already limited. The high production costs associated with disease-specific formulations further elevate retail prices, creating an affordability gap between developed and emerging markets. As a result, despite growing demand, market penetration remains constrained in economically disadvantaged regions.

Key Market Trends

Personalization in Clinical Nutrition Formulations

A growing trend in the oral clinical nutrition market is the development of personalized nutrition solutions. These are tailored to individual patient needs based on variables such as age, medical condition, genetic profile, and metabolic status. Advances in technologies like nutrigenomics and digital health tools are allowing clinicians to assess individual nutrient deficiencies and create targeted formulations that improve treatment outcomes. Personalized nutrition enhances patient compliance and efficacy, especially in complex cases such as cancer care, gastrointestinal recovery, and age-related deficiencies, thus establishing itself as a cornerstone of modern clinical nutrition strategies.

Key Market Players

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Bayer AG
• Nestle SA
• GlaxoSmithKline plc
• Baxter International Inc.
• Otsuka Holdings, Co. Ltd.
• Baxter International Inc.
• Victus, Inc.
• Danone SA (Nutricia)

Report Scope

In this report, the Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Clinical Nutrition Market, By Indication:

• Alzheimer's
• Nutritional Deficiencies
• Cancer Care
• Chronic Kidney Disease
• Dysphagia
• Others

Oral Clinical Nutrition Market, By Distribution Channel:

• Direct Sales
• Indirect Sales

Oral Clinical Nutrition Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oral Clinical Nutrition Market.

Available Customizations

Global Oral Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
  • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Map
  • 5.3.1. By Indication
  • 5.3.2. By Distribution Channel
  • 5.3.3. By Region

6. North America Oral Clinical Nutrition Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oral Clinical Nutrition Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Oral Clinical Nutrition Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. Germany Oral Clinical Nutrition Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Indication
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Oral Clinical Nutrition Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oral Clinical Nutrition Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. India Oral Clinical Nutrition Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Indication
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Indication
      • 8.3.5.2.2. By Distribution Channel

9. South America Oral Clinical Nutrition Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oral Clinical Nutrition Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. Argentina Oral Clinical Nutrition Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. Colombia Oral Clinical Nutrition Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Oral Clinical Nutrition Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Indication
  • 10.2.2. By Distribution Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oral Clinical Nutrition Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Indication
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Indication
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. UAE Oral Clinical Nutrition Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Indication
      • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Pfizer, Inc.
• 15.3. Bayer AG
• 15.4. Nestle SA
• 15.5. GlaxoSmithKline plc.
• 15.6. Baxter International Inc.
• 15.7. Otsuka Holdings, Co. Ltd.
• 15.8. Baxter International Inc.
• 15.9. Victus, Inc.
• 15.10. Danone SA(Nutricia)

16. Strategic Recommendations

17. About Us & Disclaimer